Enter Symbol:

Stock Detail

SCICLONE PHARMACEUTICALS INC

Drug Manufacturers Other

SCLN @ Yahoo Finance | SCLN Option @ Yahoo Finance

Last Day's Data

Current Price High Value Change Percent Change Dividend Previous Close
$4.46 $4.56 $-0.02 -0.45% 0.00 $4.48
Opening Price Low Volume Market Cap Average Volume P/E
$4.42 $4.41 137,256 260.87M 260,873.5 12.43

Pivot Table

R2 R1 Pivot S1 S2
4.63 4.55 4.48 4.40 4.33

stock chart

Stock Profile

SciClone Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics to treat life-threatening diseases. Its products include ZADAXIN is in phase 3 hepatitis C virus clinical trials, as well as in other late-stage clinical trials for the treatment of hepatitis B virus and certain cancers. The company also develops SCV-07, which is in preclinical studies, for the treatment of viral and other infectious diseases. The company sells its products primarily in Asia, the Middle East, and Latin America. SciClone Pharmaceuticals was founded in 1989 and is headquartered in San Mateo, California.